Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Jun 05, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
---|---|---|---|
₹42.003+0.5% 1 day change | 24.53% p.a. | ₹2,912 Crs |
Expense ratio | 0.62% as on May 31, 2025 |
Exit load | 0.5% Exit load of 0.50% if redeemed within 1 month.! |
AUM (Fund size) | ₹2,912 Crs |
Lock-in | No Lockin |
Age | 6 yrs 6 m since Nov 12, 2018 |
Benchmark | BSE Healthcare TRI |
Min. investment | SIP ₹500 & Lump. ₹500 |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, pay tax of 12.5% on returns of ₹1.25 lakh+ in a financial year |
Period | This fund | Category average |
---|---|---|
1 Month | 3.23% | 2.88% |
3 Months | 3.04% | 7.74% |
6 Months | -8.17% | -3.25% |
1 Year | 18.58% | 20.64% |
2 Years | 30.51% | 33.08% |
3 Years | 25.97% | 25.67% |
4 Years | 17.27% | 16.3% |
5 Years | 24.77% | 23.09% |
Large Cap 27.052073999999998%
Mid Cap 20.82081%
Small Cap 51.98711600000001%
Other Cap 0.0%
Healthcare 97.71000000000001%
Insurance 1.56%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Foreign - Equity 13.4%
Foreign Mutual Funds 0.59%
Reverse Repo 0.29%
Global X Genomics & Biotechnology ETF 0.59%
Others 0.29%
Fund name | ETM Rank | AUM (in Crs.) | Fund age | Expense ratio |
---|---|---|---|---|
DSP Healthcare Fund | N.A. | ₹2,912 Crs | 6 yrs 6 m | 0.62% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | ₹5,295 Crs | 6 yrs 11 m | 1.06% |
SBI Healthcare Opportunities Fund | N.A. | ₹3,671 Crs | 12 yrs 5 m | 0.9% |
Tata India Pharma & HealthCare Fund | N.A. | ₹1,223 Crs | 9 yrs 6 m | 0.63% |
Nippon India Pharma Fund | N.A. | ₹8,260 Crs | 12 yrs 5 m | 0.89% |
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
DSP Healthcare Fund | 3.23% | -8.17% | 18.58% | 25.97% | 24.77% | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 4.88% | -0.14% | 25.44% | 29.52% | 26.05% | 15.47% |
SBI Healthcare Opportunities Fund | -0.45% | -2.56% | 22.12% | 28.55% | 25.03% | 13.48% |
Tata India Pharma & HealthCare Fund | 1.73% | -3.32% | 17.87% | 25.5% | 23.11% | 13.08% |
Nippon India Pharma Fund | 3.34% | -1.17% | 17.02% | 25.52% | 22.9% | 15.77% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
DSP Healthcare Fund | 15.15 | 0.86 | 1.14 | 1.95 |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.67 | 0.95 | 1.31 | 1.94 |
SBI Healthcare Opportunities Fund | 13.98 | 0.84 | 1.4 | 2.1 |
Tata India Pharma & HealthCare Fund | 16.18 | 0.98 | 1.05 | 1.68 |
Nippon India Pharma Fund | 14.97 | 0.89 | 1.14 | 1.74 |
Alpha | 2.52 vs. 4.54 Underperformed at beating benchmark |
Sharpe | 1.14 vs. 4.87 Poor risk-adjusted returns |
Beta | 0.86 vs. 0.87 Less sensitive to market ups & downs |
Standard deviation | 15.15 vs. 9.73 More volatile performance |
Fund AUM | ₹2,912 Crs as on Mar 31, 2025 |
Scheme document | View Scheme Document |
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
No. of schemes | 50 view all schemes |
Total AUM | ₹1,87,436 Crs as on Mar 31, 2025 |
Address | NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road Junction Western Express Highway, Andheri East Mumbai, 400069 |
Phone | 1800-208-4499 / 1800-200-4499 |
Fund name | ETM Rank | AUM (in Crs.) | 1Y | 5Y |
---|---|---|---|---|
DSP India T.I.G.E.R. Fund | N.A. | ₹4,950 Crs | 2.19% | 35.58% |
DSP Small Cap Fund | N.A. | ₹14,258 Crs | 18.18% | 34.52% |
DSP Natural Resources and New Energy Fund | N.A. | ₹1,227 Crs | -1.09% | 28.45% |
DSP ELSS Tax Saver Fund | N.A. | ₹16,638 Crs | 12.98% | 26.93% |
DSP Large & Mid Cap Fund | N.A. | ₹14,387 Crs | 11.47% | 26.33% |
The current Net Asset Value (NAV) of the DSP Healthcare Fund - Direct Growth plan is approximately ₹42.003 as of Jun 05, 2025.
The DSP Healthcare Fund is a 6 yrs 6 m old fund and has delivered average annual returns of 24.53% since inception.
1-Year | 3-Year | 5-Year | Since Inception |
---|---|---|---|
18.58% | 25.97% | 24.77% | 24.53% |
The DSP Healthcare Fund - Direct Growth has an expense ratio of 0.62%, which reflects the fund's management and operating costs. This percentage is subtracted from the fund's annual returns, impacting net returns for investors.
The DSP Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately ₹2,912 Crs crore as of Mar 31, 2025.
The DSP Healthcare Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Cohance Lifesciences Ltd. | 9.72% |
Sun Pharmaceutical Industries Ltd. | 9.66% |
Cipla Ltd. | 9.53% |
Ipca Laboratories Ltd. | 8.16% |
Globus Medical Inc | 5.63% |
Apollo Hospitals Enterprise Ltd. | 4.67% |
Laurus Labs Ltd. | 4.6% |
Gland Pharma Ltd. | 4.43% |
Alembic Pharmaceuticals Ltd. | 4.29% |
Sai Life Sciences Ltd. | 3.82% |
The DSP Healthcare Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 97.71000000000001% |
Insurance | 1.56% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. It is just a matter of a few minutes. Here's how:
For the Desktop Version:
For the Mobile Version:
All set! Your investment in DSP Healthcare Fund is complete.
Redeeming your investments in DSP Healthcare Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in DSP Healthcare Fund from anywhere else, you can go to the fund house website and put a request through it.